News Announcement

Titan Bio-Tech: Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results For The Quarter & Half Year Ended September 2025.

Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve the unaudited standalone & consolidated financial results for the second quarter & half year ended September 30 2025

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.